In keeping with this hypothesis, mice injected with tumor cells that were pretreated with TGF-β but in which integrin β3 expression was silenced responded to P144 treatment with significantly impaired metastasis to the lymph nodes. This evidence concerns the gene TGFB1 and neoplasm.